Coronary Collateral Circulation: A New Predictor of Mortality in Heart Transplant Recipients With Allograft Vasculopathy

Background. Coronary collateral arteries (CCAs) are anastomotic channels between vessels; although beneficial in atherosclerosis, their role in heart transplantation (HT) recipients is underinvestigated. CCAs initially develop as microcirculation and cardiac allograft vasculopathy (CAV), promoting immune-dependent proliferative angiogenic response, and play a role in their development. In our hypothesis, ischemia induced by coronary microvascular dysfunction (CMD) triggers the development of CCAs, which are, in turn, less functional as affected by CAV themselves. Methods. One hundred twenty-one patients receiving HT at our institution were retrospectively evaluated and were included if transthoracic echocardiography with coronary flow velocity reserve (CFVR) assessment and coronary angiography were performed. CMD was defined as CFVR of ≤2.5. Patients with CAV were enrolled, and their angiograms were reviewed to evaluate the presence of CCAs. Cardiovascular mortality was assessed as the main clinical outcome. Results. Forty patients were found to have CCAs. Patients with CCAs have lower CFVR than those without CCAs (2.22 ± 0.72 versus 2.69 ± 0.92;P = 0.003), reflecting in different rates of CMD in the 2 groups (72.5% versus 37%; P < 0.001). CMD is associated with higher CAV grades (P < 0.001), which are also associated with CCAs (P < 0.001). Patients with poorly developed CCAs have lower CFVR (P < 0.001). At multivariable analysis, CMD (P = 0.008) and higher CAV grades (P = 0.005) are independent predictors of CCAs. During the median follow-up time of 10.2 (6.6-13.3) y, patients with CCAs have been found to have higher mortality than those without CCAs (57.5% versus 32.1%; P = 0.007). CCAs are associated with a lower probability of survival also in patients with CMD (P < 0.001) and are independent predictors of mortality (P < 0.001). Conclusions. Our results demonstrate an interplay between CAV, CMD, and CCAs. We confirm that CAV is associated with CMD, and we show, for the first time, that CMD is associated with CCAs. CCAs are pathophysiologically associated with more severe graft vasculopathy and independently predict mortality after HT.

[1]  J. Pober,et al.  Cardiac Allograft Vasculopathy: Current Review and Future Research Directions. , 2021, Cardiovascular research.

[2]  K. Khush,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report - 2021; Focus on recipient characteristics. , 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  C. Pepine,et al.  Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease. , 2021, International journal of cardiology.

[4]  A. Ducharme,et al.  Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation. , 2017, JACC. Heart failure.

[5]  B. Umman,et al.  Bimodal Pattern of Coronary Microvascular Involvement in Diabetes Mellitus , 2016, Journal of the American Heart Association.

[6]  G. Gerosa,et al.  Coronary Microvascular Dysfunction Correlates With the New Onset of Cardiac Allograft Vasculopathy in Heart Transplant Patients With Normal Coronary Angiography , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  A. Angelini,et al.  Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications. , 2014, World journal of transplantation.

[8]  Pascal Meier,et al.  The human coronary collateral circulation: development and clinical importance. , 2013, European heart journal.

[9]  Filippo Crea,et al.  Coronary microvascular dysfunction. , 2013, The New England journal of medicine.

[10]  G. Ewald,et al.  Coronary Collaterals Predict Improved Survival and Allograft Function in Patients With Coronary Allograft Vasculopathy , 2013, Circulation. Heart failure.

[11]  C. Seiler,et al.  The impact of the coronary collateral circulation on mortality: a meta-analysis. , 2012, European heart journal.

[12]  M. Fishbein,et al.  Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  S. Cook,et al.  Coronary collateral function in the transplanted heart: propensity score matching with coronary artery disease , 2011, Heart.

[14]  R. Starling,et al.  International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  G. Gerosa,et al.  Coronary Flow Reserve by Transthoracic Echocardiography Predicts Epicardial Intimal Thickening in Cardiac Allograft Vasculopathy , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  C. Seiler,et al.  The human coronary collateral circulation , 2010, European journal of clinical investigation.

[17]  R. Rubinshtein,et al.  Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. , 2010, European heart journal.

[18]  A. Angelini,et al.  Determinants of coronary flow reserve in heart transplantation: a study performed with contrast-enhanced echocardiography. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  Pascal Meier,et al.  Beneficial Effect of Recruitable Collaterals: A 10-Year Follow-Up Study in Patients With Stable Coronary Artery Disease Undergoing Quantitative Collateral Measurements , 2007, Circulation.

[20]  B. McManus,et al.  Allograft Vasculopathy Versus Atherosclerosis , 2006, Circulation research.

[21]  A. Angelini,et al.  Coronary Flow Velocity Pattern and Coronary Flow Reserve by Contrast-Enhanced Transthoracic Echocardiography Predict Long-Term Outcome in Heart Transplantation , 2006, Circulation.

[22]  G. Gerosa,et al.  Coronary Flow Reserve by Contrast‐Enhanced Echocardiography: A New Noninvasive Diagnostic Tool for Cardiac Allograft Vasculopathy , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  D. Grobbee,et al.  Prognostic significance of coronary collaterals in patients with coronary heart disease having percutaneous transluminal coronary angioplasty. , 2005, The American journal of cardiology.

[24]  A. Yeung,et al.  Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. , 2005, Journal of the American College of Cardiology.

[25]  A. Angelini,et al.  Immune and Nonimmune Predictors of Cardiac Allograft Vasculopathy Onset and Severity: Multivariate Risk Factor Analysis and Role of Immunosuppression , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  Diederick E Grobbee,et al.  Coronary Collaterals: An Important and Underexposed Aspect of Coronary Artery Disease , 2003, Circulation.

[27]  L. Klein,et al.  Coronary Endothelial Dysfunction After Heart Transplantation Predicts Allograft Vasculopathy and Cardiac Death , 2002, Circulation.

[28]  G. Thiene,et al.  Skin Cancer in Heart Transplant Recipients: Risk Factor Analysis and Relevance of Immunosuppressive Therapy , 2000, Circulation.

[29]  S. Iliceto,et al.  Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: comparison with intracoronary Doppler flow wire. , 1999, Journal of the American College of Cardiology.

[30]  R. Peters,et al.  Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion. , 1997, Journal of the American College of Cardiology.

[31]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[32]  S. Hunt,et al.  Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. , 1995, Circulation.

[33]  G. Vetrovec,et al.  Coronary Collateral Circulation in the Transplanted Heart , 1993, Circulation.

[34]  M. Fujita,et al.  Recent insights into coronary collateral circulation. , 1992, Circulation.

[35]  M. Hammond,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[36]  J F Silverman,et al.  Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. , 1988, Journal of the American College of Cardiology.

[37]  M. Cohen,et al.  Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. , 1985, Journal of the American College of Cardiology.

[38]  Ghassan S Kassab,et al.  Cardiac allograft vasculopathy: Microvascular arteriolar capillaries ('capioles") and survival. , 2017, Frontiers in bioscience.

[39]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[40]  W. Schaper,et al.  Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. , 1998, The Journal of clinical investigation.